Thomas Riley

Thomas Riley is a Professor at the School of Biomedical Sciences, University of Western Australia, with additional roles as Senior Clinical Scientist at PathWest Laboratory Medicine, Professorial Research Fellow at Edith Cowan University, and Professor of Public Health at Murdoch University. He holds advanced degrees including a PhD from the University of Western Australia, and is a Fellow of multiple prestigious organizations.

His research focuses on healthcare-related infections, particularly Clostridium difficile epidemiology and antimicrobial resistance. Notable contributions include over 400 publications, including 50+ studies on tea tree oil’s antimicrobial properties and over 200 on C. difficile. He has been continuously funded by the Rural Industries Research and Development Corporation since 1993.

Recent publications emphasize global healthcare epidemiology (e.g., Cambodia studies) and One Health approaches to zoonotic pathogens like C. difficile in feral horses. Key collaborations include work with institutions in Australia and Cambodia.

• Grants: Active NHMRC grant (2022–2025) on reducing C. difficile infections via systems dynamics. Previous grants include MHRIF funding (2015–2017).
• Awards: Multiple fellowships in microbiology and pathology, reflecting his leadership in the field.

His work aligns with UN Sustainable Development Goals, particularly those addressing health and environmental sustainability.